Brain metastases in triple-negative breast cancer: a systematic review of current trends, treatment strategies, and outcomes. | ClinicLens

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with a high risk of early central nervous system dissemination and poor outcomes after brain metastasis (BM). This systematic review summarizes current evidence on incidence, treatment strategies, outcome

Medical Literature · Updated 2026-08-05

← Back to articles

This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.